IRCT201205265283N4已完成2 期
Comparing the effect of Metformin and Megestrol acetate on endometrial histology in patients with disordered proliferative or hyperplastic endometrium. A RCT
Women's Reproductive Health Research Center, Tabriz University of Medical Sciences0 个研究点目标入组 90 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 60 years（—）
- 性别
- Female
入选标准
- •Patients with abnormal uterine bleeding and havingdisordered proliferative or hyperplastic endometrium with or without atypia. Consent to participate.
- •Exclusion criteria:
- •Patients who have allergy to metformin, Patients with renal failure, nausea, vomiting, anorexia, anemia, cutaneous lesionsor not satisfied to participate in the study.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
Evaluating the effect of Megestrol and metformin on women with endometrial hyperplasiaIRCT20140820018866N6Tehran University of Medical Sciences60
已完成
2 期
Comparison of metformin-megestrol combination and megestrol alone on endometrial histology in patients with disordered proliferative or hyperplastic endometrium.Patients with abnormal bleeding and endometrial proliferative and Hayprplastyk with irregular glands with and without atypia.Endometrial glandular hyperplasiaIRCT201410275283N11Vice chancellor for Research,Tabriz University Of Medical Sciences84
已完成
4 期
Treatment of endometrial hyperplasiaCondition 1: Other noninflammatory disorders of uterus, except cervix. Condition 2: Endometrial glandular hyperplasia. Condition 3: Endometrial adenomatous hyperplasia.Other noninflammatory disorders of uterus, except cervixEndometrial glandular hyperplasiaEndometrial adenomatous hyperplasiaIRCT201506252624N18Vice chancellor for research ,Iran University of Medical Sciences.36
招募中
3 期
empagliflozin effect in polycystic ovarian syndromPolycystic ovarian syndrome.Polycystic ovarian syndromeE28.2IRCT20220822055771N1Shahre-kord University of Medical Sciences50
已完成
不适用
Effect of metformin, pioglitazone and vitaminE E in patients with non-alcoholic fatty liver diseasenon-alcoholic fatty liver disease.Fatty (change of) liver, not elsewhere classifiedIRCT2016010411991N3Vice chancellor for research,Kermanshah University of Medical Sciences93